Amarin Corp Plc (AMRN)

[HDGabor]

K-

Why would Kaiser ( known for driving costs down by using generic ) be using brand V instead of generic V ?

Because
1) they know their CAD patients like me are only using it for the R-It indication … so don’t want to be dragged into a HealthNet like court case
2) AMRN gave them a lower price then the generics
3) combination of 1) and 2)

Too late for me - 2:35 AM - to jump into a long discussion .. so let assume you are right re. 2.)

The exclusivity deals are de facto generic deals .

Name any Co making significant profit selling generics

Amarin had $130 / bottle Net Revenue (NR) before the exclusive deals. In Q1 had $116 / bottle Net Revenue ... as 45% is exclusive and 55% isn't it "suggests" the exclusive NR is $100 / bottle. The COGS is app. $27 / bottle ... so the Gross Profit is still $73 / bottle meanwhile the deal is exclusive.

Furthermore I am pretty sure the generics' COGS is significantly higher than Amarin has ... and (IIRC) at least the first (and the second?) generic did not offer significantly lower price than Amarin.

Best,
G